Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Schizophrenia Drugs Said to Raise Stroke Risk in Dementia Patients
20 February 2004. The Reuters news agency reported today that Eli Lilly and Co. has notified doctors of a significant increase in the risk for stroke and death that it has observed in demented elderly patients who take its drug Zyprexa. This antipsychotic is approved for schizophrenia but is increasingly being used to treat behavioral problems, such as delusions and aggression, in people with dementia including Alzheimer’s disease. Doctors prescribe this drug for nursing home patients and others who still live at home. Such “off-label" use is legal, but Zyprexa is not officially approved for dementia. The company apparently sent a letter to doctors that it had found this increased risk in five clinical trials, the Wall Street Journal reported today. Johnson and Johnson warned last April that its schizophrenia drug Risperdal, too, increases the risk for stroke in elderly patients with dementia.—Adapted from Reuters .
 
Comments on News and Primary Papers
  Comment by:  Tomasz Sobow
Submitted 21 February 2004  |  Permalink Posted 23 February 2004

No surprise at all. As dementia patients are already at higher risk for stroke due to metabolic disturbances that are already there, both in vascular and Alzheimer's disease, not mentioning age alone...The real question is whether this is the beginning of the end of the extensive use of atypicals in schizophrenia, and, particularly, in affective disorders. Atypicals lack extrapyramidal phenotype seen for classical neuroleptics, but what if they, instead, shorten patients' lives? Large observational studies are urgently needed to establish atypicals' "real life" safety profile in every indication. "Yellow card" is already here!

View all comments by Tomasz Sobow

  Comment by:  Mary Cieri
Submitted 26 February 2004  |  Permalink Posted 1 March 2004

My father, suffering from severe dementia, was on the drug zyprexa. He was suffering from hallucinations. He thought there were people in the house who were not there. He thought my mother was someone else. He had a massive stroke 2 weeks ago and died! The stroke was a blockage, not a hemorrhage. This article is very disturbing. We had him on 2.5,5,10 and 15 and then he became very debilitated, so it was reduced slowly down to 10 and 5 and 2.5. He was completely off the drug for 1 week when he had the stroke.

View all comments by Mary Cieri

  Comment by:  Paul LaBounty
Submitted 25 May 2004  |  Permalink Posted 27 May 2004

My Mother entered a nursing home walking, talking, eating and going to the bathroom by herself. She had Alzheimer's but ate breakfast out daily. She entered the home when Dad was hospitalized with a heart attack. She was prescribed zyprexa upon admission and given the right, "to refuse to eat or drink". In approx 5 weeks, she was confined to a wheel chair unable to speak or drink or eat. Obviously, she starved. She was hospitalized for rehydration but was never the same. "The Breakfast Club" group of friends have been very supportive and adamant about her abuse. Her case is complicated because it involves a guardian who was not close to her and, of course, money.

View all comments by Paul LaBounty

  Comment by:  Gladys Brown
Submitted 5 July 2004  |  Permalink Posted 6 July 2004

My mother entered a nursing home on February 24th after having been discharged fom a hospital, where she had been treated with IV fluids for dehydration and dangerously high saline levels. At her admission to the nursing home she could walk, sometimes in need of assistance. She could speak in sentences, she could feed herself with supervision, and she could read simple signs. In addition, she could indicate her need for toileting.

The first night she was at the nursing home she alarmed the staff by being out of bed because she was looking for the toilet. She had been getting 50mg.of Seroquel at home, which enabled her to sleep at least 8 hours. She received no other neuroleptic medication during the day. The nursing home increased the dosage to 100mgof Seroquel. The report was that she was combative and needed to be controlled. By combative they meant that she was uncooperative in toileting and unspecified tasks.

In about three weeks the family noticed a decline in her ability to talk,walk, and stay awake. She had decreased ability to hold eating utensils and constantly...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad